A Study of A-101 Solution in Subjects With Common Warts.

Summary

This is a randomized, double-blind, vehicle-controlled, parallel-group study with 3 treatment groups.

Timeline

Start

2015-12-21

Primary completion

2016-09-16

Completion

2016-09-16

Outcome

Met primary endpoint

registry analysis (other test); A-101 Solution 45 vs Vehicle Solution; p = 0.009; ANCOVA NCT02669862 ↗

Drugs

Indications